NCT03500991 2025-12-17
HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
Seattle Children's Hospital
Phase 1 Active not recruiting
Seattle Children's Hospital
Universitätsklinikum Hamburg-Eppendorf
St. Jude Children's Research Hospital